Medication info
Telmisplus Tablet 80/12.5 mg

Telmisplus Tablet 80/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Samil Pharmaceutical Co., Ltd.
Appearance
White or almost white, biconvex round tablets
Packaging
10 tablets/blister x 3, 100 tablets/bottle
Approval status
Active

MFDS item code 201001021 · Notified 2010.01.29 · Insurance code 643902840

Summary

Main use
Treats essential hypertension inadequately controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide 40/12.5mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide 80/12.5mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide 80/25mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Elderly patients No dosage adjustment is required.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Samil Pharmaceutical Co., Ltd.

Efficacy & effects

Treats essential hypertension inadequately controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication can be used for the treatment of essential hypertension. It is particularly effective for patients whose blood pressure is not adequately controlled with telmisartan alone. This medication helps to reliably reduce blood pressure and mitigate the risks associated with hypertension. When used appropriately according to the patient's condition, it can be very helpful for blood pressure management. It is used to improve health through safe and consistent use.

How to take

Adult dose

Adults Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide 40/12.5mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide 80/12.5mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide 80/25mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Elderly patients No dosage adjustment is required.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so women who are pregnant or planning to become pregnant should not use it. Administration is prohibited for patients with allergies to the components of this medication or those with certain liver or kidney diseases. It should be used with caution in elderly patients or those with specific heart, liver, or kidney conditions to avoid excessive drops in blood pressure. The hydrochlorothiazide component can cause electrolyte imbalances in the body, so regular blood tests should be performed to check levels of potassium, sodium, and others. This medication can interact with other antihypertensive drugs, diuretics, lithium, etc.; therefore, it is essential to inform your doctor or pharmacist of any other medications you are taking. If unusual symptoms such as dizziness, low blood pressure, skin rash, or difficulty breathing occur while taking this medication, you should consult medical personnel immediately. Caution is needed as drowsiness or dizziness can occur while driving or operating machinery. Safety has not been established for use in children or adolescents under 18 years of age.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 116 more
  • dizziness
  • fainting
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • indigestion
  • vomiting
  • gastritis
  • abnormal liver function
  • liver disorder
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasm
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased creatine phosphokinase
  • increased liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylaxis
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • taste disturbance
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal dysfunction
  • myasthenia
  • decreased hemoglobin
  • sialadenitis
  • nonmelanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • acute respiratory distress syndrome
  • pancreatitis
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremors
  • facial flushing
  • malaise
  • fatigue
  • proteinuria
  • itching
  • myalgia
  • sensation of floating
  • lip and hand tremors
  • hypersensitivity
  • gum disease
  • dry lips
  • decreased vision
  • hypotension
  • tachycardia
  • bradycardia
  • orthostatic hypotension
  • pulmonary edema
  • acute renal failure
  • hypokalemia
  • hypochloremia
  • dehydration
  • nausea
  • somnolence
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius. This storage method helps maintain the effectiveness of the medication for a long time.

Appearance and packaging

Appearance

White or almost white, biconvex round tablets

Package unit

10 tablets/blister x 3, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.